{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:49:27Z","timestamp":1768567767737,"version":"3.49.0"},"posted":{"date-parts":[[2024,6,13]]},"group-title":"Neurology","reference-count":61,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>INTRODUCTION<\/jats:title>\n                  <jats:p>Normal pressure hydrocephalus (NPH) patients undergoing cortical shunting frequently show early AD pathology on cortical biopsy, which is predictive of progression to clinical AD. The objective of this study was to use samples from this cohort to identify CSF biomarkers for AD-related CNS pathophysiologic changes using tissue and fluids with early pathology, free of post-mortem artifact.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We analyzed Simoa, proteomic, and metabolomic CSF data from 81 patients with previously documented pathologic and transcriptomic changes.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>AD pathology on biopsy correlates with CSF \u03b2-amyloid-40\/42, neurofilament light chain (NfL), and phospho-tau-181(p-tau181)\/\u03b2-amyloid-42, while several gene expression modules correlate with NfL. Proteomic analysis highlights 7 core proteins that correlate with pathology and gene expression changes on biopsy, and metabolomic analysis of CSF identifies disease-relevant groups that correlate with biopsy data..<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>DISCUSSION<\/jats:title>\n                  <jats:p>As additional biomarkers are added to AD diagnostic panels, our work provides insight into the CNS pathophysiology these markers are tracking.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.06.11.24308706","type":"posted-content","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T10:05:21Z","timestamp":1718273121000},"source":"Crossref","is-referenced-by-count":0,"title":["Alzheimer\u2019s disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expression"],"prefix":"10.64898","author":[{"given":"Ali S.","family":"Ropri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany G.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vrinda","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather M.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marie W.","family":"Bartosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot H. H.","family":"Youth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie K.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayanta K.","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Suk","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Boyett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora F.","family":"Spinazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence S.","family":"Honig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy M.","family":"McKhann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1916-8490","authenticated-orcid":false,"given":"Andrew F.","family":"Teich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024061623400476000_2024.06.11.24308706v1.1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/1980-57642018dn13-020001","article-title":"Normal-pressure hydrocephalus: A critical review","volume":"13","year":"2019","journal-title":"Dement Neuropsychol"},{"key":"2024061623400476000_2024.06.11.24308706v1.2","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000305"},{"key":"2024061623400476000_2024.06.11.24308706v1.3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/105.1.65"},{"key":"2024061623400476000_2024.06.11.24308706v1.4","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1975.42.3.0258"},{"key":"2024061623400476000_2024.06.11.24308706v1.5","doi-asserted-by":"crossref","first-page":"E662","DOI":"10.1093\/neuros\/nyz102","article-title":"Predicting Cognitive Improvement in Normal Pressure Hydrocephalus Patients Using Preoperative Neuropsychological Testing and Cerebrospinal Fluid Biomarkers","volume":"85","year":"2019","journal-title":"Neurosurgery"},{"key":"2024061623400476000_2024.06.11.24308706v1.6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22015"},{"key":"2024061623400476000_2024.06.11.24308706v1.7","doi-asserted-by":"crossref","unstructured":"Libard S , Alafuzoff I . Alzheimer\u2019s disease neuropathological change and loss of matrix\/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer\u2019s disease. Acta neuropathologica communications. 2019;7:98.","DOI":"10.1186\/s40478-019-0748-9"},{"key":"2024061623400476000_2024.06.11.24308706v1.8","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22100"},{"key":"2024061623400476000_2024.06.11.24308706v1.9","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-190334","article-title":"Predicting Development of Alzheimer\u2019s Disease in Patients with Shunted Idiopathic Normal Pressure Hydrocephalus","volume":"71","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"2024061623400476000_2024.06.11.24308706v1.10","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41467-021-25902-y","article-title":"An immune response characterizes early Alzheimer\u2019s disease pathology and subjective cognitive impairment in hydrocephalus biopsies","volume":"12","year":"2021","journal-title":"Nat Commun"},{"key":"2024061623400476000_2024.06.11.24308706v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.08.005"},{"key":"2024061623400476000_2024.06.11.24308706v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.018"},{"key":"2024061623400476000_2024.06.11.24308706v1.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-021-02263-w"},{"key":"2024061623400476000_2024.06.11.24308706v1.14","unstructured":"S. A. FastQC: a quality control tool for high throughput sequence data."},{"key":"2024061623400476000_2024.06.11.24308706v1.15","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/18.suppl_1.S105"},{"key":"2024061623400476000_2024.06.11.24308706v1.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030161"},{"key":"2024061623400476000_2024.06.11.24308706v1.17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007"},{"key":"2024061623400476000_2024.06.11.24308706v1.18","doi-asserted-by":"crossref","unstructured":"Langfelder P , Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","DOI":"10.1186\/1471-2105-9-559"},{"key":"2024061623400476000_2024.06.11.24308706v1.19","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1021\/acs.jproteome.1c00322","article-title":"Impact of Systemic versus Intratympanic Dexamethasone Administration on the Perilymph Proteome","volume":"20","year":"2021","journal-title":"J Proteome Res"},{"key":"2024061623400476000_2024.06.11.24308706v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/S41591-020-0815-6"},{"key":"2024061623400476000_2024.06.11.24308706v1.21","doi-asserted-by":"crossref","unstructured":"Dayon L , Nunez Galindo A , Wojcik J , Cominetti O , Corthesy J , Oikonomidi A , et al. Alzheimer disease pathology and the cerebrospinal fluid proteome. Alzheimers Res Ther. 2018;10:66.","DOI":"10.1186\/s13195-018-0397-4"},{"key":"2024061623400476000_2024.06.11.24308706v1.22","doi-asserted-by":"crossref","unstructured":"Higginbotham L , Ping L , Dammer EB , Duong DM , Zhou M , Gearing M , et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease. Sci Adv. 2020;6.","DOI":"10.1126\/sciadv.aaz9360"},{"key":"2024061623400476000_2024.06.11.24308706v1.23","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201600044"},{"key":"2024061623400476000_2024.06.11.24308706v1.24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3233\/JAD-200568","article-title":"Alzheimer\u2019s Disease: Protective Effects of Mycobacterium vaccae, a Soil-Derived Mycobacterium with Anti-Inflammatory and Anti-Tubercular Properties, on the Proteomic Profiles of Plasma and Cerebrospinal Fluid in Rats","volume":"78","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"2024061623400476000_2024.06.11.24308706v1.25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3233\/JAD-201318","article-title":"Why Inclusion Matters for Alzheimer\u2019s Disease Biomarker Discovery in Plasma","volume":"79","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"2024061623400476000_2024.06.11.24308706v1.26","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41598-022-05384-8","article-title":"Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry","volume":"12","year":"2022","journal-title":"Scientific reports"},{"key":"2024061623400476000_2024.06.11.24308706v1.27","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1021\/acs.analchem.9b01974","article-title":"Evaluating Combined Precursor Isotopic Labeling and Isobaric Tagging Performance on Orbitraps To Study the Peripheral Proteome of Alzheimer\u2019s Disease","volume":"92","year":"2020","journal-title":"Anal Chem"},{"key":"2024061623400476000_2024.06.11.24308706v1.28","doi-asserted-by":"crossref","unstructured":"Pedrero-Prieto CM , Garcia-Carpintero S , Frontinan-Rubio J , Llanos-Gonzalez E , Aguilera Garcia C , Alcain FJ , et al. A comprehensive systematic review of CSF proteins and peptides that define Alzheimer\u2019s disease. Clin Proteomics. 2020;17:21.","DOI":"10.1186\/s12014-020-09276-9"},{"key":"2024061623400476000_2024.06.11.24308706v1.29","doi-asserted-by":"crossref","unstructured":"Babic Leko M , Mihelcic M , Jurasovic J , Nikolac Perkovic M , Spanic E , Sekovanic A , et al. Heavy Metals and Essential Metals Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer\u2019s Disease. Int J Mol Sci. 2022;24.","DOI":"10.3390\/ijms24010467"},{"key":"2024061623400476000_2024.06.11.24308706v1.30","doi-asserted-by":"crossref","unstructured":"Dulewicz M , Kulczynska-Przybik A , Borawska R , Slowik A , Mroczko B . Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer\u2019s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms231810867"},{"key":"2024061623400476000_2024.06.11.24308706v1.31","doi-asserted-by":"crossref","first-page":"e0233519","DOI":"10.1371\/journal.pone.0233519","article-title":"Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases","volume":"15","year":"2020","journal-title":"PLoS One"},{"key":"2024061623400476000_2024.06.11.24308706v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2020.02.008"},{"key":"2024061623400476000_2024.06.11.24308706v1.33","doi-asserted-by":"crossref","unstructured":"Teitsdottir UD , Jonsdottir MK , Lund SH , Darreh-Shori T , Snaedal J , Petersen PH . Association of glial and neuronal degeneration markers with Alzheimer\u2019s disease cerebrospinal fluid profile and cognitive functions. Alzheimers Res Ther. 2020;12:92.","DOI":"10.1186\/s13195-020-00657-8"},{"key":"2024061623400476000_2024.06.11.24308706v1.34","doi-asserted-by":"crossref","unstructured":"Dulewicz M , Kulczynska-Przybik A , Slowik A , Borawska R , Mroczko B . Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer\u2019s Disease. J Clin Med. 2021;10.","DOI":"10.3390\/jcm10194575"},{"key":"2024061623400476000_2024.06.11.24308706v1.35","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/JOM.0000000000000773","article-title":"High-Resolution Metabolomics Assessment of Military Personnel: Evaluating Analytical Strategies for Chemical Detection","volume":"58","year":"2016","journal-title":"J Occup Environ Med"},{"key":"2024061623400476000_2024.06.11.24308706v1.36","first-page":"e12025","article-title":"Differences in plasma metabolites related to Alzheimer\u2019s disease","volume":"6","year":"2020","journal-title":"APOE epsilon4 status, and ethnicity. Alzheimers Dement (N Y)"},{"key":"2024061623400476000_2024.06.11.24308706v1.37","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp291"},{"key":"2024061623400476000_2024.06.11.24308706v1.38","doi-asserted-by":"crossref","unstructured":"Uppal K , Soltow QA , Strobel FH , Pittard WS , Gernert KM , Yu T , et al. xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data. BMC Bioinformatics. 2013;14:15.","DOI":"10.1186\/1471-2105-14-15"},{"key":"2024061623400476000_2024.06.11.24308706v1.39","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts034"},{"key":"2024061623400476000_2024.06.11.24308706v1.40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003123"},{"key":"2024061623400476000_2024.06.11.24308706v1.41","doi-asserted-by":"crossref","unstructured":"Stirling DR , Swain-Bowden MJ , Lucas AM , Carpenter AE , Cimini BA , Goodman A . CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics. 2021;22:433.","DOI":"10.1186\/s12859-021-04344-9"},{"key":"2024061623400476000_2024.06.11.24308706v1.42","doi-asserted-by":"crossref","unstructured":"Hansson O , Lehmann S , Otto M , Zetterberg H , Lewczuk P . Advantages and disadvantages of the use of the CSF Amyloid beta (Abeta) 42\/40 ratio in the diagnosis of Alzheimer\u2019s Disease. Alzheimers Res Ther. 2019;11:34.","DOI":"10.1186\/s13195-019-0485-0"},{"key":"2024061623400476000_2024.06.11.24308706v1.43","doi-asserted-by":"crossref","unstructured":"Whelan CD , Mattsson N , Nagle MW , Vijayaraghavan S , Hyde C , Janelidze S , et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease. Acta neuropathologica communications. 2019;7:169.","DOI":"10.1186\/s40478-019-0795-2"},{"key":"2024061623400476000_2024.06.11.24308706v1.44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206478"},{"key":"2024061623400476000_2024.06.11.24308706v1.45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/10408363.2019.1670613","article-title":"Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer\u2019s disease: A literature review","volume":"57","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2024061623400476000_2024.06.11.24308706v1.46","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16344"},{"key":"2024061623400476000_2024.06.11.24308706v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.1004.1001"},{"key":"2024061623400476000_2024.06.11.24308706v1.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.06.027"},{"key":"2024061623400476000_2024.06.11.24308706v1.49","unstructured":"Kohlmeier M . Nutrient metabolism. Amsterdam; Boston: Academic Press; 2003."},{"key":"2024061623400476000_2024.06.11.24308706v1.50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.TM117.000259"},{"key":"2024061623400476000_2024.06.11.24308706v1.51","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5b01020"},{"key":"2024061623400476000_2024.06.11.24308706v1.52","doi-asserted-by":"crossref","unstructured":"Haukedal H , Freude KK . Implications of Glycosylation in Alzheimer\u2019s Disease. Front Neurosci. 2020;14:625348.","DOI":"10.3389\/fnins.2020.625348"},{"key":"2024061623400476000_2024.06.11.24308706v1.53","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.bbagen.2017.04.012","article-title":"N-glycan and Alzheimer\u2019s disease","volume":"1861","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2024061623400476000_2024.06.11.24308706v1.54","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-871"},{"key":"2024061623400476000_2024.06.11.24308706v1.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.06.006"},{"key":"2024061623400476000_2024.06.11.24308706v1.56","doi-asserted-by":"publisher","DOI":"10.1038\/nature21029"},{"key":"2024061623400476000_2024.06.11.24308706v1.57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2011.00550.x"},{"key":"2024061623400476000_2024.06.11.24308706v1.58","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12612"},{"key":"2024061623400476000_2024.06.11.24308706v1.59","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000271090.28148.24"},{"key":"2024061623400476000_2024.06.11.24308706v1.60","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww224"},{"key":"2024061623400476000_2024.06.11.24308706v1.61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/WNL.0000000000001834","article-title":"Mixed pathology is more likely in black than white decedents with Alzheimer dementia","volume":"85","year":"2015","journal-title":"Neurology"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.06.11.24308706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:02:57Z","timestamp":1768507377000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.06.11.24308706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":61,"URL":"https:\/\/doi.org\/10.1101\/2024.06.11.24308706","relation":{},"subject":[],"published":{"date-parts":[[2024,6,13]]},"subtype":"preprint"}}